Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 10, 1995, Pages 2918-2925

  Masamura, Shigeru ^a   Santner, Steven J ^a   Heitjan, Daniel F ^c   Santen, Richard J ^b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE;

ARTICLE; BREAST CANCER; CELL DIVISION; ENVIRONMENTAL FACTOR; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; GROWTH INHIBITION; HEREDITY; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ANIMAL; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMAN; MICE; MICE, NUDE; RECEPTORS, ESTROGEN; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0028853923     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.10.7559875     Document Type: Article

References (32)

1. Simons SS, Oshima H, Szapary D. 1992 Higher levels of control: modulation of steroid hormone-regulated gene transcription. Mol Endocrinol. 6:995-1002.
2. Crozat A, Palvimo JJ, Julkunen M, Janne O. 1992 Comparison of androgen regulation of ornithine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology. 130: 1131-1144.
3. Santen RJ, Manni A, Harvey H, Redmond C. 1990 Endocrine treatment of breast cancer in women. Endocr Rev. 11:221-265.
4. Legan SJ, Karsch FJ, Foster DL. 1977 The endocrine basis of seasonal reproductive function in the ewe. Endocrinology. 101:818-824.
5. Maruca J, Kulin HE, Santner SJ. 1983 Perturbations of negative feedback sensitivity in agonadal patients undergoing estrogen replacement therapy. J Clin Endocrinol Metab. 56:53-59.
6. Kulin HE, Moore RG, Santner SJ. 1976 Circadian rhythms in gonadotropin excretion in prepubertal and pubertal children. J Clin Endocrinol Metab. 42:770-773.
7. Kulin HE, Grumbach MM, Kaplan SL. 1969 Changing sensitivity of the pubertal hypothalamic feedback mechanism in man. Science. 166:1012-1013.
8. Santen RJ, Friend JN, Trojanowski D. 1978 Prolonged negative feedback suppression after estradiol administration: proposed mechanism of eugonadal secondary amenorrhea. J Clin Endocrinol Metab. 47:1220-1229.
9. D'Andrea AD, Yoshimura A Youssoufian H, Zan LI, Koo JW, Lodish HF. 1991 The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol. 11:1980-1987.
10. Oshima H, Simons Jr SS. 1992 Modulation of transcription factor activity by a distant steroid modulatory element. Mol Endocrinol. 6:416-428.
11. Santen RJ. 1993 Clinical use of aromatase inhibitors in breast carcinoma. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, eds. Cancer medicine, 3rd ed. 865-877
12. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. 1987 Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47:4355-4360.
13. Daly RJ, Darbre PD. 1990 Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T47D human breast cancer cells. Cancer Res. 50:5868-5875.
14. Murphy CS, Meisner LF, Wu SQ, Jordan VC. 1989 Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture. Eur J Cancer Clin Oncol. 25:1777-1788.
15. Welshons WV, Jordan VC. 1987 Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol. 23:1935-1939.
16. Albert DJ, Jonik RH, Gorzalka BB, Newlove T, Webb B, Walsh ML. 1991 Serum estradiol concentration required to maintain body weight, attractivity, proceptivity, and recaptivity in the ovariecto-mized female rat. Physiol Behav. 49:225-231.
17. Robinson SP, Jordan VC. 1989 Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse. Cancer Res. 49:1758-1762.
18. Kalbfleisch JD, Prentice RL. 1980 The statistical analysis of failure: time data. New York: Wiley and Sons.
19. Fleiss JL. 1981 Statistical methods for rates and proport' n, 2nd ed. New York: Wiley and Sons.
20. Chalbos D, Philips A, Galtier F, Rochefort H. 1993 Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF-7 cells. Endocrinology. 133:571-576.
21. Philips A, Chalbos D, Rochefort H. 1993 Estradiol increases and antiestrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem. 268:14103-14108.
22. Lippman ME, Bolan G. 1975 Oestrogen-responsive human breast cancer in long-term tissue culture. Nature. 256:592-593.
23. Bertois Y, Katzenellenbogen JA, Katzenellenbogen BS. 1986 Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA. 83:2496-2500.
24. Deleted in proof.
25. Berry M, Metzger D, Chambon P. 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promotor-context-dependent agonistic activity of the antioestrogen 4-hy-droxytamoxifen. EMBO J. 9:2811-2818.
26. Lees JA, Fawell SE, Parker MG. 1989 Identification of two transcription domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:5477-5488.
27. Labrie F, Veilleux R. 1986 A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate. 8:293-300.
28. Szapary D, Oshima H, Simons Jr SS. 1992 Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements upstream of the glucocorticoid response element. Endocrinology. 130:3492-3502.
29. Jiang S-Y, Jordan VC. 1992 Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst. 84:580-591.
30. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ. 1992 The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol. 6:157-167.
31. Soto AM, Justicia H, Wray JW, Sonnenschein C. 1991 p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect. 92:167-173.
32. Kirschenbaum A, Ren M, Levine AC. 1993 Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line. Steroids. 58:439-444.